196 related articles for article (PubMed ID: 12842291)
1. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist.
Shilling PD; Melendez G; Priebe K; Richelson E; Feifel D
Psychopharmacology (Berl); 2004 Sep; 175(3):353-9. PubMed ID: 15107967
[TBL] [Abstract][Full Text] [Related]
3. Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.
Oliveros A; Heckman MG; Del Pilar Corena-McLeod M; Williams K; Boules M; Richelson E
J Exp Biol; 2010 Dec; 213(Pt 24):4232-9. PubMed ID: 21113004
[TBL] [Abstract][Full Text] [Related]
4. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
[TBL] [Abstract][Full Text] [Related]
5. Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
Briody S; Boules M; Oliveros A; Fauq I; Richelson E
Behav Brain Res; 2010 Feb; 207(1):118-24. PubMed ID: 19800922
[TBL] [Abstract][Full Text] [Related]
6. Sensorimotor gating in neurotensin-1 receptor null mice.
Feifel D; Pang Z; Shilling PD; Melendez G; Schreiber R; Button D
Neuropharmacology; 2010 Jan; 58(1):173-8. PubMed ID: 19596359
[TBL] [Abstract][Full Text] [Related]
7. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist.
Feifel D; Reza TL; Wustrow DJ; Davis MD
J Pharmacol Exp Ther; 1999 Feb; 288(2):710-3. PubMed ID: 9918579
[TBL] [Abstract][Full Text] [Related]
8. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
Shilling PD; Feifel D
Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
[TBL] [Abstract][Full Text] [Related]
9. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
Li Z; Boules M; Williams K; Peris J; Richelson E
Brain Res; 2010 Jan; 1311():28-36. PubMed ID: 19948149
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats.
Zangrando J; Carvalheira R; Labbate G; Medeiros P; Longo BM; Melo-Thomas L; Silva RC
Behav Brain Res; 2013 Nov; 257():77-82. PubMed ID: 24045065
[TBL] [Abstract][Full Text] [Related]
11. The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating.
Feifel D; Priebe K
Psychopharmacology (Berl); 1999 Sep; 146(2):175-9. PubMed ID: 10525752
[TBL] [Abstract][Full Text] [Related]
12. Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.
Feifel D; Shilling PD; Melendez G
Behav Neurosci; 2011 Apr; 125(2):268-72. PubMed ID: 21463026
[TBL] [Abstract][Full Text] [Related]
13. Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female rats.
Kinkead B; Yan F; Owens MJ; Nemeroff CB
Psychoneuroendocrinology; 2008 Feb; 33(2):178-87. PubMed ID: 18155361
[TBL] [Abstract][Full Text] [Related]
14. A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist.
Feifel D; Melendez G; Shilling PD
Neuropsychopharmacology; 2003 Apr; 28(4):651-3. PubMed ID: 12655309
[TBL] [Abstract][Full Text] [Related]
15. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
16. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.
Binder EB; Kinkead B; Owens MJ; Kilts CD; Nemeroff CB
J Neurosci; 2001 Jan; 21(2):601-8. PubMed ID: 11160439
[TBL] [Abstract][Full Text] [Related]
17. The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Cáceda R; Binder EB; Kinkead B; Nemeroff CB
Schizophr Res; 2012 Apr; 136(1-3):88-95. PubMed ID: 22104138
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine.
Bakshi VP; Geyer MA
Psychopharmacology (Berl); 1995 Nov; 122(2):198-201. PubMed ID: 8848537
[TBL] [Abstract][Full Text] [Related]
19. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
[TBL] [Abstract][Full Text] [Related]
20. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
